Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0329 per EA under NDC 00093342501. Its NADAC has been published 227 times since Feb 23, 2022.
Strength
.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072926On Market Since
10/11/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 227 times since Feb 23, 2022, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0315 (Nov 20, 2024) |
| 52-week high | $0.0439 |
| 52-week low | $0.0329 |
| Median price | $0.0401 |
| Average price | $0.0400 |
| Largest weekly change | +28.1% (Aug 21, 2024) |
| Weeks tracked | 227 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0329 per EA (NDC 00093342501), effective Jun 24, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 17.7%. It has been tracked across 227 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Feb 23, 2022, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0315 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0401 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 38% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 00093342501) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification